Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||The development of an in vivo γ-secretase assay using zebrafish embryos|
|Other Titles:||The development of an in vivo gamma-secretase assay using zebrafish embryos|
|Citation:||Journal of Alzheimer's Disease, 2013; 36(3):521-534|
|Lachlan Wilson and Michael Lardelli|
|Abstract:||Aberrant proteolytic processing of amyloid-β protein precursor by γ-secretase complexes may result in an imbalance between production and clearance of the Aβ proteolytic product and promote neuronal dysfunction and death. Presenilin proteins form the catalytic core of γ-secretase complexes. The zebrafish, Danio rerio, is a versatile vertebrate model for investigating the molecular basis of Alzheimer's disease pathology. It possesses genes orthologous to human PSEN1 and PSEN2 (psen1 and psen2 respectively), and AβPP (appa and appb that are duplicates of an ancestral AβPP orthologue). Currently there is no in vivo assay appropriate for directly monitoring γ-secretase activity. Here, we describe such an assay in which the level of a γ-secretase substrate (a modified form of Appa protein) is observed in zebrafish embryos by western immunoblotting relative to a co-expressed protein not subject to γ-secretase activity. We have used the assay to analyze the effects on γ-secretase activity of blocking translation of transcripts of zebrafish psen1 and/or psen2.|
|Keywords:||Alzheimer's disease; amyloid-β protein precursor; assay; γ-secretase; morpholinos; presenilin; truncated protein; zebrafish|
|Rights:||© 2013 – IOS Press and the authors. All rights reserved.|
|Appears in Collections:||Genetics publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.